Roche Drops India Patent for Breast-cancer Drug

The decision comes after an Indian health ministry committee earlier this year urged the government to issue a 'compulsory license' tat would have obliged Roche to license a domestic generic firm to make a much cheaper copy. The decision comes after an Indian health ministry committee earlier this year urged the government to issue a "compulsory license" that would have obliged Roche to license a domestic generic firm to make a much cheaper copy. read more